Articles

Randomized, phase IIb study of low-dose cytarabine and lintuzumab versus low-dose cytarabine and placebo in older adults with untreated acute myeloid leukemia

Leukemia Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
Moffitt Cancer Center, Tampa, FL
University of Washington, Seattle, WA
Seattle Genetics, Inc., Bothell, WA
Seattle Genetics, Inc., Bothell, WA
Seattle Genetics, Inc., Bothell, WA
Memorial Sloan Kettering, New York, NY, USA
Vol. 98 No. 1 (2013): January, 2013 https://doi.org/10.3324/haematol.2012.066613